Opus Faveo is conducting ongoing analysis of technology commercialization policy in leading research universities, medical schools, hospitals, and other research institutions globally through a series of research studies. This analysis is examining both the goals and the effectiveness of technology commercialization efforts. The research path includes:
- Analysis of publicly-stated goals for technology commercialization (Complete)
- Creation of the Opus Faveo Innovation Impact™ Score and the related determination of key drivers for creating impact from research in such institutions, beginning with the U.S. and Canada. (Complete)
- Detailed profiles of leading institutions (Ongoing)
- Creation of database of leaders with commercialization responsibility in U.S. and Canada (Complete)
- Analysis of start-up ecosystems in leading institutions (Phase 1 Complete)
- Interviews with administration, faculty and technology commercialization professionals at institutions in the US and Canada (Ongoing)
- In-depth surveys of insitutions (Phase 1 complete)
- Addition of institutions in Mexico to knowledge base (In Process)
- Addition of institutions in Europe, Asia-Pacific, Latin America and Africa to knowledge base
Opus Faveo will be releasing reports on this research periodically. Some findings will not be released publicly, but are available for Opus Faveo CI² clients.